Xu Yun-gen, Zhang Jing-xin, Hua Wei-yi, Zhu Dong-ya
Center of Drug Discovery, China Pharmaceutical University, Nanjing 210009, China.
Yao Xue Xue Bao. 2003 Aug;38(8):586-91.
To search for novel compounds with potent nNOS inhibitory activity for the treatment of Alzheimer's disease.
The target compounds were obtained by introducing benzenealkyl groups into the structure of isothioureas. nNOS inhibitory activity assays were conducted for the target compounds.
Sixteen benzenealkyl isothiourea compounds (I1-16) were synthesized by three different synthetic methods from benzylamine (1) or (substituted) phenethylamine (2). Compounds I1-6 were synthesized from 1 or 2 by reaction with benzoyl isothiocyanate to form the corresponding benzoylthioureas 3 or 4, followed by hydrolysis with 10% sodium hydroxide solution, then S-alkylation with methyl iodide or ethyl iodide. I7-14 were synthesized from 1 or 2 by reaction with methyl isothiocyanate to form the corresponding 1, 3-disubstituted thioureas 7 or 8 which were S-alkylated with methyl iodide or ethyl iodide. I15 and I16 were synthesized from 2 by reaction with dimethyl cyanodithioimidocarbonate. The structures of compounds I1-16 were confirmed by MS, IR, 1HNMR and elementary analysis. The results of preliminary pharmacological test showed that all compounds possessed nNOS inhibitory activity, among which compounds I8, I12 and I14 had good activity.
Compounds I8, I12 and I14 showed superior pharmacological profiles to the control compound S-methyl-N-(4-methoxyphenyl) isothiourea. The IC50 values of compounds I8, I12 and I14 inhibiting nNOS were 8.13 x 10(-7) mol.L-1, 1.74 x 10(-7) and 2.23 x 10(-7) mol.L-1 respectively, and it is worth further studying.
寻找具有强效nNOS抑制活性的新型化合物用于治疗阿尔茨海默病。
通过将苯烷基引入异硫脲结构来获得目标化合物。对目标化合物进行nNOS抑制活性测定。
采用三种不同的合成方法,以苄胺(1)或(取代)苯乙胺(2)为原料合成了16种苯烷基异硫脲化合物(I1 - 16)。化合物I1 - 6由1或2与苯甲酰异硫氰酸酯反应生成相应的苯甲酰硫脲3或4,然后用10%氢氧化钠溶液水解,再用碘甲烷或碘乙烷进行S - 烷基化反应制得。I7 - 14由1或2与甲基异硫氰酸酯反应生成相应的1, 3 - 二取代硫脲7或8,再用碘甲烷或碘乙烷进行S - 烷基化反应合成。I15和I16由2与二甲基氰基二硫代亚氨基碳酸酯反应合成。通过质谱、红外光谱、1H核磁共振谱和元素分析确定了化合物I1 - 16的结构。初步药理试验结果表明,所有化合物均具有nNOS抑制活性,其中化合物I8、I12和I14具有良好的活性。
化合物I8、I12和I14显示出优于对照化合物S - 甲基 - N -(4 - 甲氧基苯基)异硫脲的药理特性。化合物I8、I12和I14抑制nNOS的IC50值分别为8.13×10(-7)mol·L-1、1.74×10(-7)和2.23×10(-7)mol·L-1,值得进一步研究。